Skip to main content
Premium Trial:

Request an Annual Quote

MDS Proteomics Likely IBM s Newest Partner - Reuters

NEW YORK, Jan 29 – The life sciences division of IBM is scheduled to announce a new proteomics alliance Tuesday and analysts have speculated that MDS Proteomics of Toronto is Big Blue’s latest partner, Reuters reported Monday.

IBM said in a media alert last week that it would hold a press conference in Canada on Tuesday to announce a new proteomics alliance with an undisclosed company. News of the press conference, which is scheduled to be held in Toronto, fueled speculation about the identity of IBM’s partner.

On Monday, Reuters cited two anonymous sources as saying that IBM’s partner was most likely MDS Proteomics of Toronto. An unnamed biotech analyst told Reuters that, besides a small proteomics company called Integrative Proteomics, there aren’t any other proteomics companies in Toronto.

An IBM spokeswoman would not comment on the report.

IBM has launched a handful of genomics partnerships since its announcement this summer that it would invest $100 million in the life sciences sector. In September, the company announced a deal to provide its DiscoveryLink data management software to Incyte.

IBM is scheduled to make the announcement Tuesday afternoon at 1 pm EST.


The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.